Section Ph 2402.01 - Definitions(a) "Board" means the New Hampshire pharmacy board as established by RSA 318:1, III and RSA 318:2.(b) "Clinical visit" means a consultation with a healthcare practitioner, other than a pharmacist, for women's health, which address contraception and age-appropriate screening.(c) "Hormonal contraceptives" means pills, patches, and rings which the United States Food and Drug Administration (FDA) classifies as available by prescription for the purpose of contraception or emergency contraception. It does not include similar items classified as "over the counter" by the FDA, including intrauterine devices, shots, or intradermal implants.(d) "Hormonal Contraceptive Self-Screening Questionnaire" means the screening tool approved by the board on November 17, 2021 and completed by the patient and utilized by a licensed pharmacist to access whether to dispense a hormonal contraceptive via standing order.(e) "Licensed pharmacist" or "pharmacist" means "licensed pharmacist" or "pharmacist" as defined in RSA 318:1, VII, namely, "when not otherwise limited, means a person holding a license under RSA 318:18 and who is, therefore legally authorized to practice the profession of pharmacy in this state."(f) "Model statewide protocol" means a protocol for dispensing hormonal contraceptives pursuant to RSA 318:47-1 jointly developed by the board of medicine, the board of nursing, and the department of health and human services.(g) "Outpatient contraceptive services" means hormonal contraceptive prescribing and dispensing services provided by the licensed pharmacist as specified in RSA 318:47-1.(h) "Practitioner" or "licensed practitioner" means "practitioner" or "licensed practitioner" as defined in RSA 318:1, XV, namely, "means any person who is lawfully entitled to prescribe, administer, dispense, or distribute legend drugs to patients."(i) "Standard algorithm" means the "Standard Procedures Algorithm for New Hampshire RPH Prescribing of Contraceptives" dated 11/17/2021 developed based upon the following select procedures and recommendations adopted by the U.S. Centers for Disease Control and Prevention: (1) U.S. Medical Eligibility Criteria (MEC) for Contraceptive Use, revised July 29, 2016, available as specified in Appendix B; and(2) U.S. Selected Practice Recommendations (SPR) for Contraceptive Use, revised July 29, 2016, available as specified in Appendix B.(j) "Standing order" means a written and signed protocol authored by one or more physicians licensed under RSA 329:12 or one or more advanced practice registered nurses licensed under RSA 326-B:18.N.H. Admin. Code § Ph 2402.01
Derived from Volume XLII Number 10, Filed March 10, 2022, Proposed by #13343, Effective 2/17/2022, Expires 2/17/2032